NEW YORK (GenomeWeb News) – Luminex reported after the close of the market Monday that its second-quarter revenues inched up 1 percent as a decline in systems and consumables sales was offset by a sharp rise in assay revenue.

The Austin, Texas-based firm reported total revenues of $48.3 million for the three months ended June 30, compared to $47.7 million for the second quarter of 2011. It missed Wall Street's consensus estimate for revenues of $49.2 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: variant linked to canine cleft lip, new compression tool, and more.

GNC will start using DNA testing to authentic the presence of plants included in its labels, following an agreement with the New York Attorney General.

Fareed Zakaria writes that instead of focusing solely on STEM-related courses, students would do well to pursue the liberal arts if they want to be technology innovators.

A Harvard Business Review study found four major patterns of gender biases and added that black and Latina scientists further had to navigate racial stereotypes.